Geisinger to address lung disease readmissions with AI

Listen
Text
  • Small
  • Medium
  • Large

Danville, Pa.-based Geisinger's Steele Institute for Healthcare Innovation plans to deploy an artificial intelligence tool at Geisinger Medical Center in Danville, AI developer Jvion confirmed July 3.

The AI tool, which Jvion brands as its "cognitive clinical success machine" solution, will help Geisinger Medical Center reduce avoidable readmissions related to chronic obstructive pulmonary disease, a group of lung diseases.

Geisinger's Steele Institute for Healthcare Innovation opted to deploy Jvion's solution at Geisinger Medical Center following a successful pilot at the health system.

"Leveraging demonstrated AI, we hope to accelerate our path to preventing patient illness and deterioration, optimizing patient care, and improving patient health outcomes," Karen Murphy, RN, PhD, executive vice president, chief innovation officer and founding director of Geisinger's Steele Institute for Healthcare Innovation said in Jvion's July 3 statement.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars